Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Suven receives product patents for neuro degenerative drug

Suven Life Science has received a patent each by Europe, Japan and New Zealand for a drug which is used in treating neuro degenerative diseases.

Suven Life has said in a BSE filing that “one process patent from Europe, one process patent from Japan and one process patent from New Zealand corresponding to the New Chemical Entities (NCEs) which are for the treatment of disorders associated with Neurodegenerative diseases.”

According to the company the patents are valid till 2034.

Read Equitypandit’s Technical Analysis on Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile